Asia Pacific Eye Health Supplement Market Size, Share, and Analysis by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

Asia Pacific Eye Health Supplement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Ingredient type (Lutein and Zeaxanthin, Antioxidants, Omega-3 fatty acids, Coenzyme Q10, Flavonoids, Astaxanthin, Alpha-Lipoic acid, Others); Indication (Age-related macular degeneration (AMD), Cataract, Dry eye syndrome, Others); and Form (Tablet, Capsule, Drops), and Countries

  • Report Date : Nov 2020
  • Report Code : TIPRE00015871
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 161
Page Updated: Nov 2020

The Asia Pacific Eye Health Supplement market is expected to reach US$ 593.12 million by 2027 from US$ 370.69 million in 2019; it is anticipated to grow at a CAGR of 6.2% during 2019–2027.



The key factors driving the market growth are increasing emphasis preventive care, considerable rise in eye diseases, and aging population. In addition, growing adoption dietary supplements and nutritional products is also expected to drive the market growth by 2027. However, high costs associated to Eye Health Supplement and limited availability of product in Asia Pacific Eye Health Supplement market is the major factor hindering the market growth in Asia Pacific. 

Eye supplements are nutritional products which care recommended to maintain eye health and good vision. The eye health supplements prominently comprises vitamin A, lutein & Zeaxanthin, omega 3 fatty acids, gamma-linoleic acid, and others. These nutritional supplements helps to sustain eye function, reduce the development of age-related eye diseases, and protect eyes against harmful light. Eye health supplements can be useful over range of eye diseases such as dry eye, age-related macular degeneration, glaucoma, diabetic retinopathy, and cataracts amongst others. Increasing prevalence of eye diseases coupled with aging population is likely to drive the growth of the eye health supplement market during the forecast period.

Growing prevalence of eye disorders and abnormalities is anticipated to drive the adoption of eye health supplements, which would eventually drive the eye health supplements market during the forecast period. For instance, according to the study in April 2019, “Prevalence of refractive errors, uncorrected refractive error, and presbyopia in adults in India, published by the Indian Journal of Ophthalmology, the prevalence of refractive errors, of at least 0.50 D of spherical equivalent ametropia was 53.1%. In addition, the prevalence of uncorrected refractive error was 10.2% in the study population. Moreover, as per a study reported by International Finance Corporation, China is witnessing a 6.0% increase in blindness cases annually, accommodating nearly one-fifth of the world’s blind population in the country.

Herbalife Nutrition Ltd., Alcon Inc., Bausch Health Companies Inc. are among the major companies in Eye Health Supplement market.

COVID-19 pandemic has become the most significant challenge across the Asia Pacific region. This challenge will be frightening the countries across the region as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of eye health supplements, resulting in a considerable price increase. Manufacturers are also experiencing raised prices and potential shortages of raw ingredients due to supply restrictions.

China Eye Health Supplement Market, Revenue and Forecast to 2027 (US$ Mn)

China Eye Health Supplement Market, Revenue and Forecast to 2027 (US$ Mn)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

ASIA PACIFIC EYE HEALTH SUPPLEMENT MARKET SEGMENTATION

ASIA PACIFIC EYE HEALTH SUPPLEMENT MARKET SEGMENTATION


By Ingredient Type

  • Lutein and Zeaxanthin
  • Antioxidants
  • Omega-3 fatty acids
  • Coenzyme Q10
  • Flavonoids
  • Astaxanthin
  • Alpha-Lipoic acid
  • Others

By Indication

  • Age-related macular degeneration (AMD)
  • Cataract
  • Dry eye syndrome
  • Others

By Forms

  • Tablet
  • Capsule
  • Drops

By Country

  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Rest of the Asia Pacific


Company Profiles

  • Nordic Naturals
  • Herbalife Nutrition Ltd.
  • The Nature's Bounty Co
  • AMWAY
  • Pfizer Inc.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Vitabiotics Ltd.
  • Alliance Pharma PLC
  • Allergan Plc.

Asia Pacific Eye Health Supplement Report Scope

Report Attribute Details
Market size in 2019 US$ 370.69 Million
Market Size by 2027 US$ 593.12 Million
Global CAGR (2019 - 2027) 6.2%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Ingredient Type
  • Lutein and Zeaxanthin
  • Antioxidants
  • Omega-3 fatty acids
  • Coenzyme Q10
  • Flavonoids
  • Astaxanthin
  • Alpha-Lipoic acid
  • Others
By Indication
  • Age-related macular degeneration
  • Cataract
  • Dry eye syndrome
By Form
  • Tablet
  • Capsule
  • Drops
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Nordic Naturals
  • Herbalife Nutrition Ltd.
  • The Nature's Bounty Co
  • AMWAY
  • Pfizer Inc.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Vitabiotics Ltd.
  • Alliance Pharma PLC
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
ISO Certified Logo